VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 124 filers reported holding VBI VACCINES INC in Q4 2020. The put-call ratio across all filers is 2.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $17,877 | -22.8% | 59,000 | -0.3% | 0.00% | – |
| Q4 2022 | $23,153 | -58.7% | 59,200 | -25.9% | 0.00% | -100.0% |
| Q3 2022 | $56,000 | -15.2% | 79,900 | -2.4% | 0.00% | 0.0% |
| Q2 2022 | $66,000 | -49.2% | 81,900 | +4.6% | 0.00% | -50.0% |
| Q1 2022 | $130,000 | -30.9% | 78,310 | -2.6% | 0.00% | -33.3% |
| Q4 2021 | $188,000 | -47.5% | 80,374 | -30.2% | 0.00% | -50.0% |
| Q3 2021 | $358,000 | -16.4% | 115,192 | -9.8% | 0.01% | -14.3% |
| Q2 2021 | $428,000 | -100.0% | 127,692 | -65.0% | 0.01% | -30.0% |
| Q1 2021 | $1,133,234,000 | +323681.1% | 364,384 | +186.4% | 0.01% | +25.0% |
| Q4 2020 | $350,000 | +11.8% | 127,242 | +16.3% | 0.01% | 0.0% |
| Q3 2020 | $313,000 | +58.1% | 109,403 | +70.9% | 0.01% | +33.3% |
| Q2 2020 | $198,000 | – | 64,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 55,042,465 | $171,182,000 | 2.49% |
| GENERAL AMERICAN INVESTORS CO INC | 1,877,497 | $5,839,000 | 0.50% |
| HighVista Strategies LLC | 41,271 | $129,000 | 0.08% |
| ArchPoint Investors | 65,000 | $202,000 | 0.06% |
| FIRST MIDWEST BANK TRUST DIVISION | 136,714 | $425,000 | 0.06% |
| FNY Investment Advisers, LLC | 24,683 | $76,000 | 0.04% |
| GRIMES & COMPANY, INC. | 257,960 | $802,000 | 0.04% |
| Cambridge Investment Research Advisors, Inc. | 2,065,953 | $6,425,000 | 0.03% |
| Ergoteles LLC | 171,127 | $532,000 | 0.02% |
| J.W. COLE ADVISORS, INC. | 71,100 | $221,000 | 0.02% |